Archive Newsletter

41. 04.01.25 -- STREAM Edition: Scalable Suspension LVV Production Platforms 4/1/2025
    04/01/25 Cell & Gene Newsletter
42. 04.01.25 -- Counting The Steps To Decentralized Personalized Therapy Manufacturing 4/1/2025
    04/01/25 Cell & Gene Newsletter
43. 03.31.25 -- Overcoming Barriers To Gene Therapy Development 3/31/2025

    03/31/25 Cell & Gene Newsletter

44. 03.31.25 -- Cell & Gene Therapy Manufacturing: Considerations For Early-Stage Companies 3/31/2025
    03/31/25 Cell & Gene Newsletter
45. 03.28.25 -- Is The BIOSECURE Act The First Real Step Toward Reshoring? 3/28/2025
    03/28/25 Cell & Gene Newsletter
46. 03.27.25 -- Explore mRNA Advancements With Engineered T7 RNA Polymerase 3/27/2025
    03/27/25 Cell & Gene Newsletter
47. 03.27.25 -- Accelerate Your AAV Journey To IND And Beyond 3/27/2025

    03/27/25 Cell & Gene Newsletter

48. 03.27.25 -- A Practical Guide To Defining Priority Data In MES 3/27/2025
    03/27/25 Cell & Gene Newsletter
49. 03.26.25 -- Expedite Your Process Development With Contract Services 3/26/2025

    03/26/25 Cell & Gene Newsletter

50. 03.26.25 -- MHRA Issues New Regulation On Modular And Point Of Care Manufacture Of ATMPs 3/26/2025
    03/26/25 Cell & Gene Newsletter